CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleRevenue is $868.96M, above the global median of $548.88M
- PositionReturn on equity is 37.9%, higher than 95% of its Specialty Chemicals peers (median 4.4%)
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.19%
Annual Rate
CNY 0.12Paid unknown
Payout Ratio
5.4%Sustainable
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
4.94BCNY737.10M · vs all stocks (USD)
Trailing P/E
27.88xvs Specialty Chemicals peers
Revenue (TTM)
5.82BCNY868.96M · vs all stocks (USD)
Profit Margin
3.04%vs Specialty Chemicals peers
Beta
0.6640xvs all stocks
52-Week Change
-11.95%vs all stocks
Forward Annual Dividend Yield
0.19%vs all stocks
Market Capitalization
4.94BCNY737.10M · vs all stocks (USD)
Enterprise Value
10.40BCNY1.55B · vs all stocks (USD)
Trailing P/E
27.88xvs Specialty Chemicals peers
Forward P/E
7.01xvs Specialty Chemicals peers
Price to Sales (TTM)
0.8465xvs Specialty Chemicals peers
Price to Book (MRQ)
10.85xvs Specialty Chemicals peers
Enterprise to Revenue
1.79xvs Specialty Chemicals peers
Enterprise to EBITDA
8.20xvs Specialty Chemicals peers
Gross Margin
28.70%vs Specialty Chemicals peers
Profit Margin
3.04%vs Specialty Chemicals peers
Operating Margin
21.04%vs Specialty Chemicals peers
Return on Assets (TTM)
7.84%vs Specialty Chemicals peers
Return on Equity (TTM)
37.88%vs Specialty Chemicals peers
Revenue (TTM)
5.82BCNY868.96M · vs all stocks (USD)
Revenue per Share (TTM)
75.74CNYUpdated Sep 22, 2026Quarterly Revenue Growth
108.70%vs Specialty Chemicals peers
Gross Profit (TTM)
1.32BCNY197.38M · vs all stocks (USD)
EBITDA (TTM)
788.48MCNY117.74M · vs all stocks (USD)
Net Income (TTM)
176.74MCNY26.39M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
271.48%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
738.03MCNY110.21M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.03BCNY-154.56M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1200CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
0.19%vs all stocks
Trailing Annual Dividend Rate
0.1230CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.19%vs all stocks
Payout Ratio
5.36%vs Specialty Chemicals peers
Minority Interest (Equity)
1.18BCNYFY2025 · Dec 31, 2025Revenue
4.83BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.01BCNYFY2025 · Dec 31, 2025Gross Profit
823.11MCNYFY2025 · Dec 31, 2025Operating Income
510.28MCNY76.20M · vs all stocks (USD)
Pre-tax Income
279.12MCNYFY2025 · Dec 31, 2025Income Tax Expense
-11.67MCNYFY2025 · Dec 31, 2025Net Income
290.79MCNYFY2025 · Dec 31, 2025EBIT
419.80MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
788.48MCNYFY2025 · Dec 31, 2025Research & Development
172.44MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
73.69MCNYFY2025 · Dec 31, 2025Other Operating Expenses
23.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
790.41KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
140.68MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4080CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4080CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
76.83MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
76.83MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
290.79MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-259.44MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-818.29MCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.55BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
365.18MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
290.79MCNYFY2025 · Dec 31, 2025Other Non-cash Items
187.54MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-800.30MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-496.32MCNYFY2025 · Dec 31, 2025Capital Expenditures
-730.34MCNYFY2025 · Dec 31, 2025Purchase of Investments
-118.00MCNYFY2025 · Dec 31, 2025Sale of Investments
176.38MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-671.96MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.90BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.30BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-194.39MCNYFY2025 · Dec 31, 2025Other Financing Charges
100.85MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
508.04MCNYFY2025 · Dec 31, 2025Shares Outstanding
76.83MSharesUpdated Sep 22, 2026Float Shares
41.58MSharesUpdated Sep 22, 2026% Held by Insiders
52.37%vs all stocks
% Held by Institutions
4.85%vs all stocks
Total Cash (MRQ)
505.18MCNY75.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.62CNYUpdated Sep 22, 2026Total Debt (MRQ)
4.55BCNY679.05M · vs all stocks (USD)
Total Debt to Equity (MRQ)
2.59xvs Specialty Chemicals peers
Current Ratio (MRQ)
0.8420xvs Specialty Chemicals peers
Book Value per Share (MRQ)
5.91CNYUpdated Sep 22, 2026Total Assets
7.13BCNY1.06B · vs all stocks (USD)
Total Current Assets
2.49BCNYFY2025 · Dec 31, 2025Total Liabilities
5.57BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.64BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.43BCNYFY2025 · Dec 31, 2025Total Current Liabilities
3.14BCNYFY2025 · Dec 31, 2025Cash
367.87MCNYFY2025 · Dec 31, 2025Cash Equivalents
61.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
428.97MCNYFY2025 · Dec 31, 2025Accounts Receivable
278.20MCNYFY2025 · Dec 31, 2025Inventory
1.06BCNYFY2025 · Dec 31, 2025Accounts Payable
842.79MCNYFY2025 · Dec 31, 2025Short-term Debt
2.13BCNYFY2025 · Dec 31, 2025Other Current Liabilities
299.62KCNYFY2025 · Dec 31, 2025Long-term Debt
1.87BCNYFY2025 · Dec 31, 2025Common Stock (Book)
76.83MCNYFY2025 · Dec 31, 2025Retained Earnings
95.71MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.56BCNY233.11M · vs all stocks (USD)
Treasury Stock
10.00MCNYFY2025 · Dec 31, 202552-Week Low
51.06CNYUpdated Sep 22, 202652-Week High
124.43CNYUpdated Sep 22, 202652-Week Change
-11.95%vs all stocks
Beta
0.6640xvs all stocks
50-Day MA
60.02CNYUpdated Sep 22, 2026200-Day MA
83.57CNYUpdated Sep 22, 2026Avg 10-Day Volume
499.85KSharesUpdated Sep 22, 2026Avg 30-Day Volume
720.53KSharesUpdated Sep 22, 2026Diluted EPS (TTM)
2.30CNYUpdated Sep 22, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 37.9%, higher than 95% of its Specialty Chemicals peers (median 4.4%)Significant
Return on equity: 0.38Industry median: 0.04Industry P95: 0.17Peers compared: 282
Debt-to-equity is 2.59×, higher than 95% of its Specialty Chemicals peers (median 0.34×)Significant
Debt-to-equity: 2.59Industry median: 0.34Industry P95: 1.27Peers compared: 282
Price-to-book is 10.85×, higher than 95% of its Specialty Chemicals peers (median 2.29×)Significant
Price-to-book: 10.85Industry median: 2.29Industry P95: 7.46Peers compared: 282
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 1.09Receivables vs revenue divergence: 3.09
Financial Health
Altman Z-Score 1.31: grey zoneSignificant
Altman Z-Score: 1.31
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Revenue is $868.96M, above the global median of $548.88MNotable
Revenue (USD): 868,964,774.211Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Nanjing Cosmos Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Piaggio & C. S.p.A.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Guangdong Enpack Packaging Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lingyuan Iron & Steel Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Urovo Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Omnia Holdings Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shang Gong Group Co., Ltd
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Shenzhen Pacific Union Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Greenway Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sunflag Iron & Steel Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Gen Digital Inc.
3 interpretationsWithin or Near the Altman Distress ZoneElevated ROE With High Debt-to-Equity and Equity MultiplierElevated Leverage on Three Denominators
Teixeira Duarte, S.A.
3 interpretationsWithin or Near the Altman Distress ZoneElevated ROE With High Debt-to-Equity and Equity MultiplierElevated Leverage on Three Denominators
Global Yatırım Holding A.Ş.
3 interpretationsWithin or Near the Altman Distress ZoneElevated ROE With High Debt-to-Equity and Equity MultiplierElevated Leverage on Three Denominators
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.